Literature DB >> 10342426

Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects.

M J Esser1, J Sawynok.   

Abstract

The present study was designed to determine whether amitriptyline, a prototypical tricyclic antidepressant, could produce pain relieving properties in a rat model of neuropathic pain. Nerve injury was produced by tight ligation of the lumbar 5th and 6th dorsal roots and this resulted in persistent stimulus evoked neuropathic pain symptoms (tactile allodynia and thermal hyperalgesia). Thermal hyperalgesia was measured using a focused light beam directed at the ventral surface of the paw while tactile allodynia was determined using Semmes-Weinstein monofilaments applied to the ventral surface of the paw. Amitriptyline was administered systemically (intraperitoneal), spinally (intrathecal cannula), and locally (subcutaneously) via direct injection into the dorsal surface of the paw. Following systemic administration, amitriptyline completely reversed thermal hyperalgesia (10 mg/kg) in the injured paw. Spinal administration of amitriptyline (60 microg) also produced an antihyperalgesic effect. Interestingly, local administration of amitriptyline (100 nmol) had an immediate antihyperalgesic effect that persisted for 120 min following administration. Amitriptyline had no alleviating effect against mechanical allodynia regardless of the route of administration, but curiously, produced hyperaesthesia in the contralateral paw. These results indicate that in the rat model of spinal nerve ligation, amitriptyline is effective in alleviating thermal hyperalgesia (systemically, spinally and locally) but is ineffective against mechanical allodynia. The peripheral efficacy of amitriptyline suggests the possibility of the development of cream formulations that may be able to increase the local concentration of amitriptyline without increasing the systemic dose and the subsequent occurrence of side effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342426     DOI: 10.1016/s0304-3959(98)00261-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  17 in total

Review 1.  Antidepressants as analgesics: an overview of central and peripheral mechanisms of action.

Authors:  J Sawynok; M J Esser; A R Reid
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

2.  The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

Authors:  Ercan Ozdemir; Sinan Gursoy; Ihsan Bagcivan
Journal:  J Physiol Sci       Date:  2012-04-29       Impact factor: 2.781

3.  Amitriptyline does not block the action of ATP at human P2X4 receptor.

Authors:  J A Sim; R A North
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 4.  Antidepressants as analgesics.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity.

Authors:  M R Hutchinson; L C Loram; Y Zhang; M Shridhar; N Rezvani; D Berkelhammer; S Phipps; P S Foster; K Landgraf; J J Falke; K C Rice; S F Maier; H Yin; L R Watkins
Journal:  Neuroscience       Date:  2010-04-08       Impact factor: 3.590

6.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

Review 7.  Pharmacologic treatment of neuropathic pain.

Authors:  M S Wallace
Journal:  Curr Pain Headache Rep       Date:  2001-04

8.  Absence of thermal hyperalgesia in serotonin transporter-deficient mice.

Authors:  Carola Vogel; Rainald Mössner; Manfred Gerlach; Thoralf Heinemann; Dennis L Murphy; Peter Riederer; Klaus-Peter Lesch; Claudia Sommer
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Neuropathic and inflammatory pain are modulated by tuberoinfundibular peptide of 39 residues.

Authors:  Eugene L Dimitrov; Jonathan Kuo; Kenji Kohno; Ted B Usdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

10.  Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

Authors:  Josée Guindon; Yvonne Lai; Sara M Takacs; Heather B Bradshaw; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2012-11-02       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.